Literature DB >> 15123813

CD81 is an entry coreceptor for hepatitis C virus.

Emmanuel G Cormier1, Fay Tsamis, Francis Kajumo, Robert J Durso, Jason P Gardner, Tatjana Dragic.   

Abstract

Hepatitis C virus (HCV) envelope glycoproteins E1/E2 can pseudotype retroviral particles and efficiently mediate entry into target cells. Using this experimental system, we determined HCV tropism for different cell types. Only primary hepatocytes and one hepatoma cell line were susceptible to HCV pseudovirus entry, which could be inhibited by sera from HCV-infected individuals. Furthermore, expression of the putative HCV receptor CD81 on nonpermissive human hepatic but not murine cells enabled HCV pseudovirus entry. Importantly, inhibition of viral entry by an anti-CD81 mAb occurred at a step following HCV attachment to target cells. Our results indicate that CD81 functions as a post-attachment entry coreceptor and that other cellular factors act in concert with CD81 to mediate HCV binding and entry into hepatocytes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15123813      PMCID: PMC409908          DOI: 10.1073/pnas.0402253101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages.

Authors:  B Lee; M Sharron; L J Montaner; D Weissman; R W Doms
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

2.  Nucleotide and amino acid complexity of hepatitis C virus quasispecies in serum and liver.

Authors:  B Cabot; M Martell; J I Esteban; S Sauleda; T Otero; R Esteban; J Guàrdia; J Gómez
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus.

Authors:  Jason P Gardner; Robert J Durso; Robert R Arrigale; Gerald P Donovan; Paul J Maddon; Tatjana Dragic; William C Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-03       Impact factor: 11.205

4.  Functional analysis of cell surface-expressed hepatitis C virus E2 glycoprotein.

Authors:  M Flint; J M Thomas; C M Maidens; C Shotton; S Levy; W S Barclay; J A McKeating
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

5.  Ultrastructural visualization of hepatitis C virus components in human and primate liver biopsies.

Authors:  Rita De Vos; Chris Verslype; Erik Depla; Johan Fevery; Boudewijn Van Damme; Valeer Desmet; Tania Roskams
Journal:  J Hepatol       Date:  2002-09       Impact factor: 25.083

Review 6.  Genetic diversity and models of viral evolution for the hepatitis C virus.

Authors:  M P H Stumpf; O G Pybus
Journal:  FEMS Microbiol Lett       Date:  2002-09-10       Impact factor: 2.742

7.  The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus.

Authors:  Elisa Scarselli; Helenia Ansuini; Raffaele Cerino; Rosa Maria Roccasecca; Stefano Acali; Gessica Filocamo; Cinzia Traboni; Alfredo Nicosia; Riccardo Cortese; Alessandra Vitelli
Journal:  EMBO J       Date:  2002-10-01       Impact factor: 11.598

8.  Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR.

Authors:  Stefan Pöhlmann; Jie Zhang; Frédéric Baribaud; Zhiwei Chen; George J Leslie; George Lin; Angela Granelli-Piperno; Robert W Doms; Charles M Rice; Jane A McKeating
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

9.  Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection.

Authors:  Vicky M-H Sung; Shigetaka Shimodaira; Alison L Doughty; Gaston R Picchio; Huong Can; T S Benedict Yen; Karen L Lindsay; Alexandra M Levine; Michael M C Lai
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

10.  Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes.

Authors:  Birke Bartosch; Jean Dubuisson; François-Loïc Cosset
Journal:  J Exp Med       Date:  2003-03-03       Impact factor: 14.307

View more
  116 in total

1.  Impact of intra- and interspecies variation of occludin on its function as coreceptor for authentic hepatitis C virus particles.

Authors:  Sandra Ciesek; Sandra Westhaus; Melanie Wicht; Ilka Wappler; Sylvana Henschen; Christoph Sarrazin; Nabila Hamdi; Ahmed I Abdelaziz; Christian P Strassburg; Heiner Wedemeyer; Michael P Manns; Thomas Pietschmann; Thomas von Hahn
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

2.  A human claudin-1-derived peptide inhibits hepatitis C virus entry.

Authors:  Youhui Si; Shufeng Liu; Xiuying Liu; Jana L Jacobs; Min Cheng; Yuqiang Niu; Qi Jin; Tianyi Wang; Wei Yang
Journal:  Hepatology       Date:  2012-06-11       Impact factor: 17.425

3.  Hepatitis C virus replication and potential targets for direct-acting agents.

Authors:  Jacqueline G O'Leary; Gary L Davis
Journal:  Therap Adv Gastroenterol       Date:  2010-01       Impact factor: 4.409

4.  Monoclonal antibody AP33 defines a broadly neutralizing epitope on the hepatitis C virus E2 envelope glycoprotein.

Authors:  Ania Owsianka; Alexander W Tarr; Vicky S Juttla; Dimitri Lavillette; Birke Bartosch; François-Loïc Cosset; Jonathan K Ball; Arvind H Patel
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

5.  The level of CD81 cell surface expression is a key determinant for productive entry of hepatitis C virus into host cells.

Authors:  George Koutsoudakis; Eva Herrmann; Stephanie Kallis; Ralf Bartenschlager; Thomas Pietschmann
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

6.  Hepatitis C virus resistance to broadly neutralizing antibodies measured using replication-competent virus and pseudoparticles.

Authors:  Lisa N Wasilewski; Stuart C Ray; Justin R Bailey
Journal:  J Gen Virol       Date:  2016-09-21       Impact factor: 3.891

7.  Differential effects of hepatitis C virus JFH1 on human myeloid and plasmacytoid dendritic cells.

Authors:  Hua Liang; Rodney S Russell; Nicole L Yonkers; David McDonald; Benigno Rodriguez; Clifford V Harding; Donald D Anthony
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

8.  Residues in a highly conserved claudin-1 motif are required for hepatitis C virus entry and mediate the formation of cell-cell contacts.

Authors:  Lisa Cukierman; Laurent Meertens; Claire Bertaux; Francis Kajumo; Tatjana Dragic
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

Review 9.  Progress towards recombinant anti-infective antibodies.

Authors:  Jennifer C Pai; Jamie N Sutherland; Jennifer A Maynard
Journal:  Recent Pat Antiinfect Drug Discov       Date:  2009-01

10.  Novel function of CD81 in controlling hepatitis C virus replication.

Authors:  Yong-Yuan Zhang; Bai-Hua Zhang; Koji Ishii; T Jake Liang
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.